What ARA-290 is
ARA-290 is erythropoietin-derived peptide. neuropathy and inflammation research. It sits within connective-tissue repair research (tendon, ligament, gut lining). Pepture keeps ARA-290 in the library as a tracking target only, the app records what you enter but makes no recommendation about whether the compound is appropriate for you. That decision belongs with a licensed clinician.
Published pharmacokinetic data places the half-life of ARA-290 at roughly 2 hours, and doses recorded in the community cluster around the 2 mg to 8 mg range. Individual protocols vary widely. Jurisdictional status (FDA-approved, prescription, or research only) depends on the specific formulation and country.
How people track ARA-290
In Pepture, ARA-290 is typically logged alongside range-of-motion ratings, site rotation heatmap, recovery scores, so cycle impact can be reviewed at the end of a block rather than by memory. The app captures dose, site, reconstitution ratio, cycle day, and any subjective rating you choose to add.
If you are considering ARA-290 but have not started, or if you have started and want a second opinion, speak with a licensed clinician before changing any dose or cycle pattern.
Reconstitution math
Open the pre-filled ARA-290 reconstitution calculator to compute syringe units per dose.
Reported Side Effects of ARA-290
Effects below are summarised from peer-reviewed literature or regulatory labeling where it exists. Not medical advice. Individual responses vary.
- Local injection-site reactions including transient redness and soreness PubMed
- Mild fatigue or lightheadedness reported in the first days of a protocol PubMed
- Gastrointestinal upset if dosed orally PubMed
- Isolated reports of allergic reaction; discontinue and seek care if rash or swelling occurs DailyMed
Used in these Pepture routines
ARA-290 appears in the following Pepture stack templates. Tap to load the full routine.
Compare ARA-290
How ARA-290 stacks up against the peers most users consider.